Seletracetam

From Self-sufficiency
Revision as of 15:25, 27 August 2010 by حسن علي البط (Talk) (Adding category Category:Butyramides (using HotCat))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Seletracetam
150px
150px
Systematic (IUPAC) name
(2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Unscheduled (US)
Pharmacokinetic data
Bioavailability >90%
Biological half-life 8h
Identifiers
CAS Number 357336-74-4
ATC code none
PubChem CID 9942725
Chemical data
Formula C10H14F2N2O
Molar mass 232.227[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.

See also


it:Seletracetam